Search results
Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal...
Nature· 4 days agoCompared to N235, MN235 exhibits varied enhancement in neutralization against pseudotyped and authentic viruses in vitro. The intranasal administration of MN235 in low doses can effectively ...
Mechanistic insights into SARS-CoV-2 spike protein induction of the chemokine CXCL10 - Scientific...
Nature· 2 days agoDuring a SARS-CoV-2 infection, macrophages recognize viral components resulting in cytokine production. While this response fuels virus elimination, overexpression of cytokines can lead to severe ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 2 days agoThe most recent data for Connecticut, from late April, indicates that KP.2 accounts for 24 percent...
There's a new highly transmissible COVID-19 variant: Could FLiRT lead to a summer uptick?
Medical Xpress· 4 days agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis -...
Benzinga· 2 days agoCelldex Therapeutics, Inc. CLDX today announced that the first patient has been dosed in the Company's Phase 2 subcutaneous study of barzolvolimab in prurigo nodularis (PN). Barzolvolimab is ...
AI system can predict the structures of life's molecules with stunning accuracy
Phys.org· 4 days agoPredicting protein structures and the way they interact with other molecules has been one of the...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 3 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Significant milestone ...
Covid subvariants leading infections | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 5 days agoTwo new covid-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks· 4 days agoMerck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.